Cargando…
A methylomics‐associated nomogram predicts recurrence‐free survival of thyroid papillary carcinoma
BACKGROUND: Thyroid papillary carcinoma (TPC) is the most common type of thyroid cancer (TC). The prognosis of TPC patients with tumor‐cell metastasis is poor. Therefore, this study aims to develop a model for predicting TPC patients' recurrence‐free survival (RFS). METHODS: We included 546 TPC...
Autores principales: | Chen, Hengyu, Ma, Xianxiong, Yang, Ming, Wang, Mengyi, Li, Lei, Huang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541134/ https://www.ncbi.nlm.nih.gov/pubmed/32783399 http://dx.doi.org/10.1002/cam4.3388 |
Ejemplares similares
-
Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management
por: Chen, Hengyu, et al.
Publicado: (2020) -
Development and validation of a nomogram based on stromal score to predict progression‐free survival of patients with papillary thyroid carcinoma
por: Tang, Jiajia, et al.
Publicado: (2021) -
A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021) -
DNA methylation profiling to predict overall survival risk in gastric cancer: development and validation of a nomogram to optimize clinical management
por: Ma, Xianxiong, et al.
Publicado: (2020) -
Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)